Onto Innovation ONTO 深 滬
等待開盤 05-28 09:30:00 美东时间
266.89
-7.280
-2.66%
華盛通- 最 高284.69
- 今 開284.69
- 成交量 106.02万股
- 最 低 261.86
- 昨 收 274.17
- 總市值 132.76亿
- 52周最高 316.00
- 市盈率 靜 96.16
- 換手率 2.13%
- 52周最低 89.40
- 委 比 37.93%
- 總股本 4974.36万
- 歷史最高 316.00
- 量 比 0.56
- 振 幅 8.33%
- 歷史最低 20.32
- 每 手 1
- 風險率 61.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多新“散户大佬”横空出世！一篇帖子引爆欧洲小型芯片制造商X-Fab Silicon Foundries股价暴涨超70%
曾在2021年掀起游戏驿站(GME.US)逼空大战的美国散户传奇仍令华尔街记忆犹新，如今，欧洲市场似乎也迎来了属于自己的“散户大佬”。 周三，欧洲小型芯片制造商...
05-27 23:58
Shares of semiconductor and chip companies are trading higher amid optimism that the U.S. and Iran are moving towards a negotiated resolution to the Middle East conflict, possibly delivering lower inflation and interest rates.
Shares of semiconductor and chip companies are trading higher amid optimism tha...
05-27 00:46
Onto Innovation Issues $1.5 Billion Convertible Notes
Onto Innovation ( ($ONTO) ) just unveiled an update. On May 21, 2026, Onto Inno...
05-22 06:44
Onto Innovation to offer $1.1B convertible senior notes
Onto Innovation (ONTO) plans to offer $1.1B aggregate principal amount of convertible senior notes due 2031. The company also expects to grant to the initial purchasers of the notes an option to purch...
05-18 20:04
Onto Innovation Announces Intended Offering Of $1.1B Of Convertible Senior Notes Due 2031
Onto Innovation also expects to grant to the initial purchasers of the Notes an option to purchase up to an additional $165,000,000 aggregate principal amount of the Notes, for settlement within a 13-day period beginning
05-18 19:38
Onto Innovation plans USD 1.1 billion convertible senior notes due 2031
Onto Innovation plans USD 1.1 billion convertible senior notes due 2031 Onto Innovation plans a private offering of USD 1.1 billion convertible senior notes due 2031, with an option for initial purchasers to buy up to an additional USD 165 million. Total potential issuance size of up to USD 1.27 bil
05-18 19:32
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
盘后暴涨7.73%！股价再创新高！AI推动MKS仪器业绩超预期！华尔街纷纷唱多！（附季报详解）
（来源：invest wallstreet） MKS仪器公司（NASDAQ:MKSI）公布第一季度业绩，表现全面超越分析师预期。调整后每股收益为$2.30，高于...
05-07 08:04
